Trials / Conditions / Stage II Prostate Cancer

Stage II Prostate Cancer

21 registered clinical trials studyying Stage II Prostate Cancer — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) NCT06811454	Case Comprehensive Cancer Center	N/A
Completed	Ask Questions (ASQ):Implementation of a Communication Intervention NCT05025748	Barbara Ann Karmanos Cancer Institute	N/A
Active Not Recruiting	Researching the Effect of Exercise on Cancer NCT04589468	Memorial Sloan Kettering Cancer Center	N/A
Completed	Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer NCT03963739	Wake Forest University Health Sciences	—
Active Not Recruiting	Acupuncture Pilot Study for Cancer-related Cognitive Function NCT04007770	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostat NCT03880422	Roswell Park Cancer Institute	N/A
Completed	Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer NCT03103321	Alliance for Clinical Trials in Oncology	Phase 3
Completed	Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer NCT03122743	Wake Forest University Health Sciences	—
Completed	Visually Enhanced Education About Prostate Cancer NCT02846870	Vanderbilt-Ingram Cancer Center	N/A
Completed	Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Pro NCT03233555	Rutgers, The State University of New Jersey	N/A
Terminated	Genistein in Treating Patients With Prostate Cancer NCT01126879	Northwestern University	Phase 2
Completed	Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer NCT01117935	Virginia Commonwealth University	N/A
Completed	Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer NCT01023061	University of Washington	Phase 2
Completed	MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate NCT01028885	Abramson Cancer Center at Penn Medicine	Phase 1
Withdrawn	Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate NCT00598858	John P. Fruehauf	Phase 2
Completed	Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer NCT00450749	National Cancer Institute (NCI)	Phase 2
Completed	Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostat NCT00459407	National Cancer Institute (NCI)	Phase 1
Completed	Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer NCT00450229	National Cancer Institute (NCI)	Phase 1
Completed	Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery NCT00438464	National Cancer Institute (NCI)	Phase 2
Completed	Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostat NCT00466752	University of Washington	Phase 2
Terminated	ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate NCT00544076	City of Hope Medical Center	Phase 3